Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man.

Astrup A, Toubro S.

Int J Obes Relat Metab Disord. 1993 Feb;17 Suppl 1:S41-3.

PMID:
8384179
2.

Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study.

Astrup A, Toubro S, Cannon S, Hein P, Madsen J.

Metabolism. 1991 Mar;40(3):323-9.

PMID:
2000046
3.

Pharmacology of thermogenic drugs.

Astrup A, Toubro S, Christensen NJ, Quaade F.

Am J Clin Nutr. 1992 Jan;55(1 Suppl):246S-248S. Review.

PMID:
1345887
4.

The thermogenic properties of ephedrine/methylxanthine mixtures: human studies.

Dulloo AG, Miller DS.

Int J Obes. 1986;10(6):467-81.

PMID:
3804564
5.

The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.

Astrup A, Buemann B, Christensen NJ, Toubro S, Thorbek G, Victor OJ, Quaade F.

Metabolism. 1992 Jul;41(7):686-8.

PMID:
1619985
6.
7.
9.

Peripheral mechanisms of thermogenesis induced by ephedrine and caffeine in brown adipose tissue.

Dulloo AG, Seydoux J, Girardier L.

Int J Obes. 1991 May;15(5):317-26.

PMID:
1885257
10.

Pharmacological and clinical studies of ephedrine and other thermogenic agonists.

Astrup A, Breum L, Toubro S.

Obes Res. 1995 Nov;3 Suppl 4:537S-540S. Review.

11.

The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.

Toubro S, Astrup A, Breum L, Quaade F.

Int J Obes Relat Metab Disord. 1993 Dec;17 Suppl 3:S73-7; discussion S82.

PMID:
8124407
12.

Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women.

Horton TJ, Geissler CA.

Int J Obes Relat Metab Disord. 1996 Feb;20(2):91-7.

PMID:
8646257
13.

Mechanism of enhanced cold tolerance by an ephedrine-caffeine mixture in humans.

Vallerand AL, Jacobs I, Kavanagh MF.

J Appl Physiol (1985). 1989 Jul;67(1):438-44.

PMID:
2759973
14.
15.

The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies.

Dulloo AG, Miller DS.

Am J Clin Nutr. 1986 Mar;43(3):388-94.

PMID:
3953478
16.

Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.

Bracale R, Petroni ML, Davinelli S, Bracale U, Scapagnini G, Carruba MO, Nisoli E.

PLoS One. 2014 Jun 6;9(6):e98244. doi: 10.1371/journal.pone.0098244. eCollection 2014.

17.

Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans.

Liu YL, Toubro S, Astrup A, Stock MJ.

Int J Obes Relat Metab Disord. 1995 Sep;19(9):678-85.

PMID:
8574280
18.

Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.

Haller CA, Jacob P 3rd, Benowitz NL.

Clin Pharmacol Ther. 2004 Apr;75(4):259-73.

PMID:
15060505
19.

Reduced adipsin expression in murine obesity: effect of age and treatment with the sympathomimetic-thermogenic drug mixture ephedrine and caffeine.

Lowell BB, Napolitano A, Usher P, Dulloo AG, Rosen BS, Spiegelman BM, Flier JS.

Endocrinology. 1990 Mar;126(3):1514-20.

PMID:
2307116
20.
Items per page

Supplemental Content

Write to the Help Desk